Mingozzi, Federico
Spark Therapeutics, Inc.,
United States
2025 Rank: 33299
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 120 out of 66225 Researchers
Data For The Year: 2025
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 33299 | 34505 |
| Total Cites | 1792 | 1999 |
| H-index | 22 | 22 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 272 | 286 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 800 | 872 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 855 | 893 |
| Ratio of Total Citations to Distinct Citing Papers | 2.10 | 2.24 |
| Self-Citation Percentage |
10.36%
|
|
Mingozzi, Federico
Généthon,
France
2024 Rank: 22893
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 85 out of 62673 Researchers
Data For The Year: 2024
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 22893 | 24667 |
| Total Cites | 1783 | 1964 |
| H-index | 20 | 21 |
| Hm-index | 7 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 282 | 291 |
| Number of Single+First+Last Authored Papers | 55 | 55 |
| Total Cites to Single+First+Last Authored Papers | 814 | 869 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 827 | 861 |
| Ratio of Total Citations to Distinct Citing Papers | 2.16 | 2.28 |
| Self-Citation Percentage |
9.22%
|
|
Mingozzi, Federico
Généthon,
France
2023 Rank: 31560
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 109 out of 59267 Researchers
Data For The Year: 2023
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 31560 | 32344 |
| Total Cites | 1665 | 1829 |
| H-index | 23 | 24 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 1 | 1 |
| Number of Single+First Authored Papers | 19 | 19 |
| Total Cites to Single+First Authored Papers | 255 | 266 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 766 | 818 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 788 | 828 |
| Ratio of Total Citations to Distinct Citing Papers | 2.11 | 2.21 |
| Self-Citation Percentage |
8.97%
|
|
Mingozzi, Federico
Spark Therapeutics, Inc.,
United States
2022 Rank: 24538
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 74 out of 56174 Researchers
Data For The Year: 2022
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 24538 | 23664 |
| Total Cites | 1678 | 1924 |
| H-index | 20 | 22 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 288 | 313 |
| Number of Single+First+Last Authored Papers | 53 | 53 |
| Total Cites to Single+First+Last Authored Papers | 758 | 842 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 756 | 810 |
| Ratio of Total Citations to Distinct Citing Papers | 2.22 | 2.38 |
| Self-Citation Percentage |
12.79%
|
|
Mingozzi, Federico
Généthon,
France
2021 Rank: 27397
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Clinical Medicine
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 88 out of 52513 Researchers
Data For The Year: 2021
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 27397 | 26484 |
| Total Cites | 2458 | 2847 |
| H-index | 24 | 26 |
| Hm-index | 8 | 9 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 3 | 3 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 445 | 495 |
| Number of Single+First+Last Authored Papers | 49 | 49 |
| Total Cites to Single+First+Last Authored Papers | 1066 | 1206 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 1134 | 1209 |
| Ratio of Total Citations to Distinct Citing Papers | 2.17 | 2.35 |
| Self-Citation Percentage |
13.66%
|
|
Mingozzi, Federico
Généthon,
France
2020 Rank: 32453
Overall Rank
Rank in SubField 1
Publications
Citations
Main Field:
Enabling & Strategic Technologies
SubField 1:
Biotechnology
SubField 2:
Immunology
Rank in SubField 1: 104 out of 50343 Researchers
Data For The Year: 2020
| Metrics | Self-Citations Excluded | All |
|---|---|---|
| Rank Based on Composite Score | 32453 | 26999 |
| Total Cites | 1653 | 2030 |
| H-index | 21 | 24 |
| Hm-index | 6 | 7 |
| Number of Single Authored Papers | 1 | 1 |
| Total Cites to Single Authored Papers | 2 | 2 |
| Number of Single+First Authored Papers | 18 | 18 |
| Total Cites to Single+First Authored Papers | 335 | 391 |
| Number of Single+First+Last Authored Papers | 43 | 43 |
| Total Cites to Single+First+Last Authored Papers | 648 | 777 |
| Composite Score | 3 | 3 |
| Number of Distinct Citing Papers | 747 | 805 |
| Ratio of Total Citations to Distinct Citing Papers | 2.21 | 2.52 |
| Self-Citation Percentage |
18.57%
|
|
Related Profiles
Featured Profiles
Partner with TOPSCINET
Reach science enthusiasts and researchers across the site. Write to business@topscinet.com and our marketing team will send a proposal built around your banner ad goals.